244 related articles for article (PubMed ID: 35588102)
41. Regulation of the MDM2-p53 pathway by the ubiquitin ligase HERC2.
García-Cano J; Sánchez-Tena S; Sala-Gaston J; Figueras A; Viñals F; Bartrons R; Ventura F; Rosa JL
Mol Oncol; 2020 Jan; 14(1):69-86. PubMed ID: 31665549
[TBL] [Abstract][Full Text] [Related]
42. MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation.
Fu W; Ma Q; Chen L; Li P; Zhang M; Ramamoorthy S; Nawaz Z; Shimojima T; Wang H; Yang Y; Shen Z; Zhang Y; Zhang X; Nicosia SV; Zhang Y; Pledger JW; Chen J; Bai W
J Biol Chem; 2009 May; 284(21):13987-4000. PubMed ID: 19321440
[TBL] [Abstract][Full Text] [Related]
43. UBE4B, a ubiquitin chain assembly factor, is required for MDM2-mediated p53 polyubiquitination and degradation.
Wu H; Leng RP
Cell Cycle; 2011 Jun; 10(12):1912-5. PubMed ID: 21558803
[TBL] [Abstract][Full Text] [Related]
44. The long and the short of it: the MDM4 tail so far.
Haupt S; Mejía-Hernández JO; Vijayakumaran R; Keam SP; Haupt Y
J Mol Cell Biol; 2019 Mar; 11(3):231-244. PubMed ID: 30689920
[TBL] [Abstract][Full Text] [Related]
45. ATM activates p53 by regulating MDM2 oligomerization and E3 processivity.
Cheng Q; Chen L; Li Z; Lane WS; Chen J
EMBO J; 2009 Dec; 28(24):3857-67. PubMed ID: 19816404
[TBL] [Abstract][Full Text] [Related]
46. MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4.
Marcar L; Ihrig B; Hourihan J; Bray SE; Quinlan PR; Jordan LB; Thompson AM; Hupp TR; Meek DW
PLoS One; 2015; 10(5):e0127713. PubMed ID: 26001071
[TBL] [Abstract][Full Text] [Related]
47. Ribosomal protein S7 is both a regulator and a substrate of MDM2.
Zhu Y; Poyurovsky MV; Li Y; Biderman L; Stahl J; Jacq X; Prives C
Mol Cell; 2009 Aug; 35(3):316-26. PubMed ID: 19683495
[TBL] [Abstract][Full Text] [Related]
48. Cryptic in vitro ubiquitin ligase activity of HDMX towards p53 is probably regulated by an induced fit mechanism.
Calderon-González KG; Medina-Medina I; Haronikova L; Hernychova L; Bonczek O; Uhrik L; Hrabal V; Vojtesek B; Fahraeus R; Hernández-Monge J; Olivares-Illana V
Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35674210
[TBL] [Abstract][Full Text] [Related]
49. A second p53 binding site in the central domain of Mdm2 is essential for p53 ubiquitination.
Ma J; Martin JD; Zhang H; Auger KR; Ho TF; Kirkpatrick RB; Grooms MH; Johanson KO; Tummino PJ; Copeland RA; Lai Z
Biochemistry; 2006 Aug; 45(30):9238-45. PubMed ID: 16866370
[TBL] [Abstract][Full Text] [Related]
50. Mdm2 and Mdm4 loss regulates distinct p53 activities.
Barboza JA; Iwakuma T; Terzian T; El-Naggar AK; Lozano G
Mol Cancer Res; 2008 Jun; 6(6):947-54. PubMed ID: 18567799
[TBL] [Abstract][Full Text] [Related]
51. Critical contribution of the MDM2 acidic domain to p53 ubiquitination.
Kawai H; Wiederschain D; Yuan ZM
Mol Cell Biol; 2003 Jul; 23(14):4939-47. PubMed ID: 12832479
[TBL] [Abstract][Full Text] [Related]
52. MdmX protein is essential for Mdm2 protein-mediated p53 polyubiquitination.
Wang X; Wang J; Jiang X
J Biol Chem; 2011 Jul; 286(27):23725-34. PubMed ID: 21572037
[TBL] [Abstract][Full Text] [Related]
53. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
[TBL] [Abstract][Full Text] [Related]
54. The anaphase-promoting complex/cyclosome is an E3 ubiquitin ligase for Mdm2.
He Y; Tollini L; Kim TH; Itahana Y; Zhang Y
Cell Cycle; 2014; 13(13):2101-9. PubMed ID: 24804778
[TBL] [Abstract][Full Text] [Related]
55. Mdm2 promotes Cdc25C protein degradation and delays cell cycle progression through the G2/M phase.
Giono LE; Resnick-Silverman L; Carvajal LA; St Clair S; Manfredi JJ
Oncogene; 2017 Dec; 36(49):6762-6773. PubMed ID: 28806397
[TBL] [Abstract][Full Text] [Related]
56. Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development.
Xiong S; Van Pelt CS; Elizondo-Fraire AC; Liu G; Lozano G
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3226-31. PubMed ID: 16492743
[TBL] [Abstract][Full Text] [Related]
57. Dissecting the p53-Mdm2 feedback loop in vivo: uncoupling the role in p53 stability and activity.
Pant V; Lozano G
Oncotarget; 2014 Mar; 5(5):1149-56. PubMed ID: 24658419
[TBL] [Abstract][Full Text] [Related]
58. Regulation of p53: a collaboration between Mdm2 and Mdmx.
Pei D; Zhang Y; Zheng J
Oncotarget; 2012 Mar; 3(3):228-35. PubMed ID: 22410433
[TBL] [Abstract][Full Text] [Related]
59. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53.
Parant J; Chavez-Reyes A; Little NA; Yan W; Reinke V; Jochemsen AG; Lozano G
Nat Genet; 2001 Sep; 29(1):92-5. PubMed ID: 11528400
[TBL] [Abstract][Full Text] [Related]
60. Regulation of MDM2 Stability After DNA Damage.
Li J; Kurokawa M
J Cell Physiol; 2015 Oct; 230(10):2318-27. PubMed ID: 25808808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
